Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer
B T Brett, S C Smith, C V Bouvier, et al.
European Journal of Gastroenterology & Hepatology
|
October 11, 2005
Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease
D N Samonakis, A Quaglia, N M Joshi, et al.
Endocrine-Related Cancer
|
June 24, 2024
Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study
E Baudin, J Capdevila, D Hörsch, et al.
British Journal of Cancer
|
March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
N C Turner, S J Strauss, D Sarker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 10, 2015
Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression
R Ramachandran, P Bech, K G Murphy, et al.
Gut
|
November 5, 2011
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K Ramage, A Ahmed, J Ardill, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2002
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer
B T Brett, S C Smith, C V Bouvier, et al.
European Journal of Gastroenterology & Hepatology
|
October 11, 2005
Obstructive jaundice secondary to neuroendocrine tumour in a patient with von Recklinghausen's disease
D N Samonakis, A Quaglia, N M Joshi, et al.
Endocrine-Related Cancer
|
June 24, 2024
Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study
E Baudin, J Capdevila, D Hörsch, et al.
British Journal of Cancer
|
March 18, 2010
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
N C Turner, S J Strauss, D Sarker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 10, 2015
Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression
R Ramachandran, P Bech, K G Murphy, et al.
Gut
|
November 5, 2011
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K Ramage, A Ahmed, J Ardill, et al.
Page
of 4